First, to evaluate the number of Th17 and Treg cells in different phases of MS, part of CD4+ T cells yielded from MACS were stained with FoxP3, RORγt and CD4 antibodies as explained in materials and methods. The gene discussed is CD4; the disease is myeloid sarcoma.